Organisms multiply only when the conditions are beneficial, and when not multiplying, they concentrate on survival of environmental stress. Many bacteria that harm humans survive for most of the period of infection in a lowgrowth state. This book addresses the basic scientific aspects of microbial dormancy and low-growth states, and places them in the context of human medicine. The book introduces basic scientific aspects of bacterial growth, non-growth, culturability, and viability. Later chapters cover the crucial relationship between low-growth states and survival of stress, the survival of the immune response, and interbacterial signalling. This is followed by chapters on aspects that are of direct importance to medicine, namely antibiotic resistance arising in stationary phase, biofilms, tuberculosis, and the bacteria, which cause gastric ulcers. 
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AMCM ADVANCES IN MOLECULAR AND
Over the past decade, the rapid development of an array of techniques in the fields of cellular and molecular biology has transformed whole areas of research across the biological sciences. Microbiology has perhaps been influenced most of all. Our understanding of microbial diversity and evolutionary biology, and of how pathogenic bacteria and viruses interact with their animal and plant hosts at the molecular level, for example, has been revolutionized. Perhaps the most exciting recent advance in microbiology has been the development of the interface discipline of cellular microbiology, a fusion of classic microbiology, microbial molecular biology, and eukaryotic cellular and molecular biology. Cellular microbiology is revealing how pathogenic bacteria interact with host cells in what is turning out to be a complex evolutionary battle of competing gene products. Molecular and cellular biology are no longer discrete subject areas but vital tools and integrated parts of current microbiological research. As part of this revolution in molecular biology, the genomes of a growing number of pathogenic and model bacteria have been fully sequenced, with immense implications for our future understanding of micro-organisms at the molecular level.
Advances in Molecular and Cellular Microbiology is a series edited by researchers active in these exciting and rapidly expanding fields. Each volume will focus on a particular aspect of cellular or molecular microbiology, and will provide an overview of the area, as well as examining current research. This series will enable graduate students and researchers to keep up with the rapidly diversifying literature in current microbiological research.
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Every effort has been made in preparing this book to provide accurate and up-to-date information that is in accord with accepted standards and practice at the time of publication. Although case histories are drawn from actual cases, every effort has been made to disguise the identities of the individuals involved. Nevertheless, the authors, editors, and publishers can make no warranties that the information contained herein is totally free from error, not least because clinical standards are constantly changing through research and regulation. The authors, editors, and publishers therefore disclaim all liability for direct or consequential damages resulting from the use of material contained in this book. Readers are strongly advised to pay careful attention to information provided by the manufacturer of any drugs or equipment that they plan to use.
